Our proprietary photo-crosslinked hydrogels uniquely enable
bioadhesion, tissue regeneration, tunable mechanics, and therapeutic loading across modalities from small molecules to cell and gene therapies.

 

 

 

 

GelMEDIX's proprietary injectable, in situ forming hydrogel technology overcomes the fundamental challenges of cell replacement therapies and has been shown in vivo to improve cell localization and phenotype post-injection.

​

Our lead program is an integrated hydrogel cell therapy designed to
restore vision for patients suffering from retinal disease.